Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT03153436

The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation

Sponsor: Ajyal Hospital

Conditions Cryopreservation Human Myoinositol Sperm

Interventions Myoinositol

Updated 5 times since 2017 Last updated: May 13, 2017 Started: Aug 28, 2016 Primary completion: Apr 26, 2017 Completion: Apr 26, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Cryopreservation and Human, this trial is completed. The trial is conducted by Ajyal Hospital and has accumulated 5 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jul 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ajyal Hospital
Sohag University

Data source: Sohag University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.